CD4 and colorectal carcinoma: However, while their analysis of CCR9 did not show any differences, our results showed a significant decrease in the percentage of CCR9+ among CD8+ T lymphocytes in tumor compared to unaffected tissue, and CCR9+CD4+ T lymphocytes were numerically but not significantly fewer in CRC tissue.